(MedPage Today) — Elevated plasma tau phosphorylated at threonine 217 (p-tau217) foreshadowed cognitive decline and progression to dementia in people with Down syndrome, data from the longitudinal Alzheimer’s Biomarker Consortium-Down Syndrome…
Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/116378
Author :
Publish date : 2025-07-03 16:00:00
Copyright for syndicated content belongs to the linked Source.
